SARMS or Selective Androgen Receptor Modulators are a fresh class of androgens that work similarly as anabolic steroids and prohormones minus the common side effects steroids bring. Many athletes and bodybuilders have switched to SARMS as it is safer and more effective in building muscles and increasing stamina without putting the health at risk.
One SARM that is making waves today is LGD-2226 – a SARM in its pre-clinical phase that is being developed as a cure for muscle wasting and osteoporosis. Information is still limited, but here’s what we know about LGD-2226 as of the moment:
What Is LGD-2226?
LGD-2226 is an orally active, powerful and selective agonist for androgen receptors (AR) which was believed to have anabolic effects in both muscle and bone tissue, but with significantly fewer effects on prostate weight and luteinizing hormone (a hormone produced in the pituitary gland in both men and women) levels as compared to testosterone.
Chemical Name: 6-(bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one
Molecular Formula: C14H9F9N2O
Possible Benefits of LGD-2226
- Anabolism – promotion of lean muscle tissue and mass development
- Fat loss
- Strength booster
- Enhanced bone density
- Increased strength
- Low to no virilization (development of male physical characteristics in females)
- No estrogen conversion
- Nutrient efficacy
- Improved libido
Based on the information collected, LGD-2226 is still in Phase I scientific trials so it has fairly a long way to go before becoming available and when that time comes, it will most probably be a prescription medicine.
Know more about LGD-2226 in this article.